Early Detection, founded in 2017 by Kim Vanderlinden, Gary McAdam, and AbulKalam Shamsuddin, is a San Diego-based company focused on revolutionizing cancer screening. Their core mission is to transform how doctors and patients detect and defeat cancer through non-invasive, accurate tests. The company’s flagship product, EarlyTest, aims to enable point-of-care cancer detection at all stages and assess future cancer risks directly in a doctor's office, significantly improving patient survival rates.
Notable figures affiliated with Early Detection include its founders, who bring extensive expertise in medical research and technology. The company has garnered attention for its innovative approach to cancer screening, potentially setting new standards in early detection. By providing accessible and reliable testing methods, Early Detection is poised to make a substantial impact on public health, aiming to save lives through earlier diagnosis and treatment of cancer.
